The FDA, and scientists around the world, discovered a cancer-causing compound (NDMA) in Zantac and other brands of generic ranitidine (one of the most commercially successful heartburn drugs in history). Zantac, and its generic equivalents, have been pulled from store shelves.
This is the timeline on the Zantac recall:
1983
Glaxo receives FDA approval for Zantac as a short-term treatment of a common form of ulcers and was approved in dozens of countries around the world. (More recently it has become scientifically accepted that most ulcers actually come from the H.Pylori bacteria and not from stomach acid).
1988
Zantac quickly becomes one of best-selling drugs in the world with over a billion dollars annual revenues.
1997
Glaxo’s U.S. patent for ranitidine expires and competitors launch generic alternatives to the drug. Generic manufacturers and Glaxo continue to make Zantac (ranitidine).
2004-2017
Pfizer starts making non-prescription Zantac in the U.S. The over-the- counter (non-prescription) brand of Zantac was bought and sold and is eventually acquired by Sanofi SA (generally considered the third largest pharmaceutical company in the world.
2018
FDA recalls blood pressure drug valsartan made in China after finding the cancer causing impurity N-nitrosodimethylamine (NDMA). This causes increased scrutiny of drugs that may contain the NDMA toxin.
Sept. 18, 2019
Due to the presence of the NDMA toxin in ranitidine (the chemical in Zantac) Novartis says it is halting the distribution of its generic versions of Zantac all over the world. Canada stops distribution of Zantac/ranitadine.
Sept. 28, 2019
CVS, Walmart, Walgreens and RiteAid pharmacies stop selling Zantac and their own generic ranitidine products.
Oct 2, 2019
FDA confirms it has found “unacceptable levels” of N- nitrosodimethylamine (NDMA) in samples of drugs containing ranitidine/Zantac in its testing.
Oct 8, 2019
Glaxo, the original maker Zantac, recalls prescription Zantac around the world.
Oct 18, 2019
Sanofi, the maker of the “over-the-counter” non-prescription Zantac, recalls Zantac in the United States and Canada.
PRESENT: The dangerous concentrations of NDMA in Zantac are believed to cause regular users of Zantac the following cancers of the digestive system and related major organs: Esophageal cancer, Stomach cancer, Bladder cancer, Kidney cancer, Pancreatic cancer, Colon cancer, Liver cancer and Prostate cancer (if under 65 years old at time of diagnosis). The attorneys at TheLawFirm.com have spent over 20 years helping victims of greedy pharmaceutical companies. Call The Bagneris Firm now, if you or a loved one has been diagnosed with one of the above cancers after at least one year of regular use of Zantac.
HOW YOU QUALIFY:
- Must have taken Zantac regularly prior to cancer diagnosis
- Must have been diagnosed with one of the following cancers:
- Esophageal cancer
- Stomach cancer
- Bladder cancer
- Kidney cancer
- Pancreatic cancer
- Colon cancer
- Liver cancer
- Intestinal Cancer
- Colorectal Cancer
- Breast Cancer
- Ovarian Cancer
- Testicular Cancer
- Prostate cancer (If under 65 years old at time of diagnosis).
- Diagnosis of cancer after the year 2000
If you feel like you meet the qualifications and have a valid Zantac claim, please visit our Contact Page or call us at 504-810-3995.
